← Evidence map

TrialBrain : a journal of neurology2009

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.

Marinos C Dalakas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

68 papers cite itlatest 60 shown

2009
…
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 19454532